OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
LTQ Orbitrap Velos
(1)
Q Exactive
(1)
Publication Date
2019
(1)
Release Date
2022
(1)
2021
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.
Not available
S-EPMC8785197
|
biostudies-literature
Cite
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Not available
S-EPMC7472711
|
biostudies-literature
Cite
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Not available
S-EPMC8313815
|
biostudies-literature
Cite
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Explore This Study at the NCI Proteomic Data Commons
ORGANISM(S):
Homo Sapiens (ncbitaxon:9606)
2019-08-28
|
MSV000084246
|
MassIVE
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets